76 related articles for article (PubMed ID: 17286029)
1. [Poor access to antiretroviral treatment in French-speaking Africa: situation in 2004].
Boisseau C; Degui H; Bruneton C; Rey JL
Med Trop (Mars); 2006 Dec; 66(6):589-92. PubMed ID: 17286029
[TBL] [Abstract][Full Text] [Related]
2. [Free dispensing of antiretroviral treatments in Africa].
Taverne B
Bull Soc Pathol Exot; 2003 Aug; 96(3):241-4. PubMed ID: 14582303
[TBL] [Abstract][Full Text] [Related]
3. [Access to essential medicines in Africa: a global approach].
Millot G
Med Trop (Mars); 2006 Dec; 66(6):558-64. PubMed ID: 17286021
[TBL] [Abstract][Full Text] [Related]
4. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
Bobrova N; Sarang A; Stuikyte R; Lezhentsev K
Int J Drug Policy; 2007 Aug; 18(4):313-8. PubMed ID: 17689380
[TBL] [Abstract][Full Text] [Related]
5. Negotiating antiretroviral drug prices: the experience of the Andean countries.
Seoane-Vazquez E; Rodriguez-Monguio R
Health Policy Plan; 2007 Mar; 22(2):63-72. PubMed ID: 17299024
[TBL] [Abstract][Full Text] [Related]
6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
7. [1986-2006: 20 years of failed international policy to control AIDS in Africa].
Kerouedan D
Med Trop (Mars); 2007 Oct; 67(5):515-28. PubMed ID: 18225738
[TBL] [Abstract][Full Text] [Related]
8. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
Tetteh Ek
Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
[TBL] [Abstract][Full Text] [Related]
9. [Drug supply for HIV patients in day care centre in Republic of Congo: the French Red Cross experience].
Libaudière C; Sibille B; Bakala N; Tran-Minh T; Mouala C; Adam G; Mattei JF
Med Trop (Mars); 2006 Dec; 66(6):598-601. PubMed ID: 17286031
[TBL] [Abstract][Full Text] [Related]
10. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria.
Uzochukwu BS; Onwujekwe OE; Onoka AC; Okoli C; Uguru NP; Chukwuogo OI
Health Policy Plan; 2009 May; 24(3):189-96. PubMed ID: 19276155
[TBL] [Abstract][Full Text] [Related]
11. [Ten years of commitment to persons living with HIV-AIDS: evaluation of the management in three ambulatory treatment centers of the French Red Cross in Africa].
Mouala C; Madec Y; Adam G; Courpotin C; Fikouma V; Gentilini M; Ould Mohamedoune A; Nzounza P; Schaer E; Simon B; Mattei JF
Sante; 2008; 18(2):89-95. PubMed ID: 19188132
[TBL] [Abstract][Full Text] [Related]
12. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
Tetteh E
Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
[No Abstract] [Full Text] [Related]
13. Reforming antiretroviral price negotiations and public procurement: the Mexican experience.
Adesina A; Wirtz VJ; Dratler S
Health Policy Plan; 2013 Jan; 28(1):1-10. PubMed ID: 22375026
[TBL] [Abstract][Full Text] [Related]
14. The obligation to provide antiretroviral treatment in HIV prevention trials.
Lo B; Padian N; Barnes M
AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of compliance with ARV treatment in Africa].
Mouala C; Roux P; Okome M; Sentenac S; Okome F; Nziengui U; Olivier F; Benjaber K; Rey JL
Med Trop (Mars); 2006 Dec; 66(6):610-4. PubMed ID: 17286034
[TBL] [Abstract][Full Text] [Related]
16. Global progress in PMTCT and paediatric HIV care and treatment in low- and middle-income countries in 2004-2005.
Luo C; Akwara P; Ngongo N; Doughty P; Gass R; Ekpini R; Crowley S; Hayashi C
Reprod Health Matters; 2007 Nov; 15(30):179-89. PubMed ID: 17938083
[TBL] [Abstract][Full Text] [Related]
17. Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens.
Renaud-Théry F; Nguimfack BD; Vitoria M; Lee E; Graaff P; Samb B; Perriëns J
AIDS; 2007 Jul; 21 Suppl 4():S89-95. PubMed ID: 17620758
[TBL] [Abstract][Full Text] [Related]
18. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
Ojikutu B
J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
[TBL] [Abstract][Full Text] [Related]
19. Barriers to access to antiretroviral treatment in developing countries: a review.
Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
[TBL] [Abstract][Full Text] [Related]
20. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
